Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
Epiomic Epidemiology Series: Testicular Cancer Forecast in 24 Major Markets 2018–2028
US$ 5,800.00
... Epiomic Epidemiology Forecast Report on Testicular Cancer in 24 Major Markets Testicular cancer is a relatively rare cancer; although it is the most commonly diagnosed cancer in males aged 20–34. There are two main types of testicular cancer ... testicular cancer patients. Identification of testicular cancer ...
December 2017
68 pages
Epiomic Epidemiology Series: Thyroid Cancer Forecast in 21 Major Markets 2018–2028
US$ 5,800.00
... Epiomic Epidemiology Forecast Report on Thyroid Cancer in 21 Major Markets Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. It is a relatively rare cancer ... the incident population of thyroid cancer patients. Identification of thyroid cancer patient sub-populations that ...
December 2017
76 pages
Prostate Cancer: Update Bulletin [January 2018]
US$ 1,095.00
... patients with newly diagnosed, high-risk, metastatic hormone-sensitive prostate cancer (mHSPC); Bavarian Nordic’s announcement that it was discontinuing ... Xofigo (radium-223 dichloride) in combination with J&J's Zytiga in patients with prostate cancer as a result of an imbalance of more fractures and deaths in ...
December 2017
North America Protein Purification and Isolation Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
US$ 2,500.00
... into: Technology Product Type Application End-User The North America protein purification & isolation market is segmented on the basis of ... in the forecast period 2018 to 2025. Based on geography, the North America protein purification & isolation market is segmented into geographical regions, such as, U.S., ...
December 2017
363 pages
In Vitro Diagnostics (IVD) Market
US$ 3,619.00
... expected to impede the growth in the IVD industry. In Vitro Diagnostics (IVD) Market Key Segmentation: The report encompasses the IVD market segmentation based on product type, technique, indication ...
December 2017
Ovarian Cancer - Pipeline Review, H2 2017
US$ 2,500.00
... releases. The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2017
2232 pages
Exocrine Pancreatic Insufficiency - Pipeline Review, H2 2017
US$ 2,000.00
... releases. The Exocrine Pancreatic Insufficiency (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Exocrine Pancreatic Insufficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2017
44 pages
Global Cancer Diagnostics market and Drivers, Restraints, and Opportunities 2018-2024
US$ 2,750.00
... are some of the factors hampering the market growth to an extent. Market Analysis: The “Global Cancer Diagnostics Market” is estimated to witness a CAGR ... The global cancer diagnostics market by application is segmented into lung cancer, breast cancer, Colorectal cancer, prostate cancer and others. Lung cancer ...
December 2017
118 pages
Global Sexually-Transmitted Diseases (STD) Market Country Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers
US$ 9,600.00
... com contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts ... of leading suppliers. The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, ...
December 2017
Europe Sexually-Transmitted Diseases (STD) Market Country Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers
US$ 7,900.00
... from VPGMarketResearch.com provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales ... leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific ...
December 2017
